Adarza BioSystems Receives $5,000,000 Series B Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a3e65771-8fbd-4112-a483-5dfcad88617d - Date
3/22/2016 - Company Name
Adarza BioSystems - Mailing Address
150 Lucius Gordon Drive West Henrietta, NY 14586 USA - Company Description
Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples. - Website
http://www.adarzabio.com - Transaction Type
Venture Equity - Transaction Amount
$5,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform. Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules. - M&A Terms
- Venture Investor
Cultivation Capital - Venture Investor
Lewis & Clark Ventures - Venture Investor
Siemens Venture Capital
